{
  "id": "allergic-contact-dermatitis",
  "title": "Allergic Contact Dermatitis",
  "lang": "en",
  "source_lang": "en",
  "summary": "Allergic contact dermatitis is a delayed, T-cell-mediated skin inflammation caused by contact with a substance to which a person has become sensitized.",
  "category": "health",
  "subcategory": "diseases",
  "type": "concept",
  "aliases": [
    "Allergic contact eczema",
    "Contact allergy dermatitis"
  ],
  "generated_at": "2026-11-02",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/allergic-contact-dermatitis/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/allergic-contact-dermatitis/",
      "json": "https://aiwiki.page/zh/allergic-contact-dermatitis.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Allergic contact dermatitis is an inflammatory skin disease caused by a delayed immune reaction to a substance that contacts the skin. It is a form of eczema and typically produces itching, redness or other inflammatory color changes, swelling, and, during acute episodes, small blisters or weeping. Repeated exposure may instead produce thickened, scaly, fissured skin. Common causes include nickel, fragrance ingredients, preservatives, rubber chemicals, hair dyes, and certain topical medicines.\n\nThe disease develops through sensitization: an initial exposure establishes immune memory, and subsequent exposure can provoke dermatitis. Unlike immediate forms of allergy, the reaction is mediated principally by T lymphocytes rather than allergen-specific IgE antibodies. Symptoms usually emerge over hours to days, making the responsible exposure less obvious than in an immediate allergic reaction. A substance tolerated for years can become a cause after sensitization develops.\n\nAllergic contact dermatitis matters both as a common clinical problem and as an occupational disease. It can interfere with sleep, manual work, personal care, and continued employment. Its investigation combines the distribution and timing of the eruption with a detailed exposure history and, when appropriate, standardized patch testing. Distinguishing clinically relevant allergy from irritation or incidental sensitization is central to understanding the disease."
    },
    {
      "heading": "Disease boundaries, frequency, and susceptibility",
      "text": "Allergic contact dermatitis belongs to the broader group of contact dermatitis, which also includes irritant contact dermatitis. The distinction concerns mechanism rather than appearance. In allergic disease, a substance provokes a specific response by the immune system in a sensitized person. In irritant disease, physical or chemical injury disrupts the skin barrier and initiates inflammation without requiring prior allergen-specific sensitization. Both mechanisms can operate in the same patient, particularly on the hands.\n\nContact sensitization and allergic contact dermatitis are related but different states. Sensitization means that the immune system can recognize a substance and produce a delayed response, usually demonstrated by a positive patch test. Dermatitis requires a sufficient exposure at an appropriate site under conditions that permit the reaction to develop. Someone with a positive nickel test may have no current disease if meaningful nickel exposure is absent. Consequently, population studies of positive patch tests do not directly measure the frequency of active allergic contact dermatitis.\n\nThe epidemiology of the disease varies with consumer products, occupations, cultural practices, and regulation. Nickel is a frequent sensitizer in many populations, while the relative importance of preservatives, dyes, adhesives, and rubber accelerators changes over time. Patients referred to specialist patch-test clinics are a selected population with suspected contact allergy; their allergen frequencies cannot be applied directly to the general population. Differences in test panels and reading schedules also complicate comparisons between countries and periods.\n\nSusceptibility reflects both exposure and host factors. Repeated application, high concentrations, prolonged contact, occlusion, and a damaged barrier can increase the opportunity for sensitization. Wet work and detergents may first cause irritation, which then facilitates allergen penetration. Atopic dermatitis can complicate this relationship: its barrier abnormalities and frequent use of skin products increase exposure opportunities, but contact allergy is not simply an inevitable consequence of atopy. The strength of the sensitizer and the particular exposure pattern remain important.\n\nChildren can develop contact allergy, including to metals, fragrances, preservatives, and adhesives used with medical devices. Older adults may have substantial exposure to topical medicines, dressings, and compression products, especially when chronic leg disease disrupts the skin barrier. Sex-associated differences in sensitization often reflect different exposures, such as jewelry, cosmetics, or particular occupations, rather than a single intrinsic biological explanation. The disease is not contagious, and its occurrence does not by itself indicate generalized immune deficiency."
    },
    {
      "heading": "Sensitization and the delayed immune response",
      "text": "The classical mechanism is type IV hypersensitivity, a delayed immune response mediated by T cells. Many contact allergens are small reactive chemicals that act as haptens: they become immunologically recognizable after binding to skin proteins. Some substances require chemical oxidation outside the body or metabolism within the skin before becoming sensitizing. These are often called prehaptens and prohaptens, respectively. Oxidation products of certain fragrance terpenes illustrate why an ingredient’s allergenic properties can change during storage and exposure to air.\n\nDuring the sensitization phase, an allergen penetrates the outer skin barrier and interacts with proteins and cells in the epidermis. Keratinocytes contribute danger signals and inflammatory mediators. Antigen-presenting cells, including epidermal Langerhans cells and dermal dendritic cells, acquire allergenic material and migrate to a draining lymph node. There they help activate T cells capable of recognizing the relevant antigenic structures. The resulting population includes effector cells and long-lived memory cells.\n\nSensitization generally develops over days to weeks, although its timing varies with the substance and exposure. It may occur without a visible eruption. Once established, immune memory can persist for many years. Not every contact with a sensitizer produces clinical sensitization: the delivered dose, barrier penetration, inflammatory context, and regulatory immune responses all affect the outcome. Strong sensitizers may induce allergy at relatively low exposures, whereas weaker sensitizers generally require more favorable conditions.\n\nDuring elicitation, renewed exposure activates allergen-specific memory T cells in the skin and recruits additional inflammatory cells. Both CD4 and CD8 T-cell populations can participate. Their cytokines and cytotoxic effects alter keratinocyte function, promote vascular changes, and contribute to epidermal injury. Tissue-resident memory T cells help explain why previously affected sites may respond rapidly on re-exposure. Although clinical disease often becomes evident within 24–72 hours, onset and peak intensity vary, and some allergens produce later reactions.\n\nThe biology is more diverse than a single uniform pathway. Different allergens can induce different mixtures of T-cell responses, and innate immune activation is integral to sensitization. Nickel, for example, can activate human Toll-like receptor 4 as part of its inflammatory effects. Immune regulation also limits reactions; a positive exposure does not inevitably produce maximal inflammation. The clinical eruption therefore reflects an interaction among antigen recognition, barrier condition, local tissue memory, exposure dose, and regulatory mechanisms rather than the presence of an allergy-specific circulating antibody alone."
    },
    {
      "heading": "Major allergens and exposure sources",
      "text": "Metals are among the best-known causes. Nickel can be released from jewelry, clothing fasteners, tools, and other metal objects, particularly under conditions involving sweat and prolonged skin contact. Cobalt occurs in alloys, pigments, and occupational materials and may accompany nickel exposure, although the two allergies are immunologically distinct. Chromium allergy is associated with chromate-containing cement and some leather products. The allergenic form and its availability matter: the mere presence of a metal in an object does not establish that enough is released to cause dermatitis.\n\nFragrances comprise many chemically distinct substances rather than one allergen. They occur in perfumes, cosmetics, toiletries, household cleaners, and some products marketed primarily for skin care. Limonene and linalool can form sensitizing hydroperoxides after oxidation. Preservatives are another major group because water-containing products require protection against microbial growth. Methylisothiazolinone and methylchloroisothiazolinone became especially important in contact-allergy surveillance during the 2000s and 2010s. Formaldehyde and formaldehyde-releasing preservatives provide additional examples; reactions to a releaser and to formaldehyde are not interchangeable in every patient.\n\nHair dyes, nail products, and adhesives create distinctive exposure patterns. Para-phenylenediamine, often abbreviated PPD, is an important allergen in oxidative hair dyes and can be present at high concentrations in so-called black henna preparations. Acrylate and methacrylate monomers occur in artificial nail systems, dental materials, industrial resins, and some medical adhesives. Uncured monomers are generally more relevant to sensitization than fully polymerized material, although residual monomers and other components can remain clinically important. Eyelid dermatitis may result from transfer of nail-product allergens by the fingers rather than direct application to the eyelids.\n\nRubber-related allergy requires separation of delayed and immediate mechanisms. Thiurams, dithiocarbamates, mercaptobenzothiazole-related compounds, and other manufacturing chemicals can cause delayed dermatitis from gloves, footwear, and elastic materials. Immediate allergy to natural rubber latex proteins is a different condition and may cause urticaria or systemic reactions. A glove described as latex-free can still contain rubber accelerators capable of causing allergic contact dermatitis.\n\nPlants and topical medicines are further major sources. Urushiol in poison ivy, poison oak, and poison sumac causes characteristic plant dermatitis. Sesquiterpene lactones in some Asteraceae plants can affect gardeners and others with repeated exposure. Topical antibiotics such as neomycin and bacitracin, local anesthetics, and even corticosteroids can become allergens. In wound care, the responsible exposure may instead be an adhesive, dressing component, preservative, or vehicle ingredient. A product’s therapeutic purpose, botanical origin, or “natural” labeling does not establish that it lacks sensitizing potential."
    },
    {
      "heading": "Clinical appearance and patterns of distribution",
      "text": "The clinical appearance depends on reaction intensity, anatomical site, exposure duration, and background skin characteristics. Acute disease typically features intense itching, swelling, papules, and small vesicles; severe episodes can produce larger blisters and oozing. Erythema may appear pink or red in lighter skin, while inflammatory change in darker skin can be less conspicuous or appear violaceous, grayish, or dark brown. Residual pigment alteration may remain after the active inflammation has subsided.\n\nSubacute and chronic disease often shows scaling, dryness, fissuring, and lichenification, the thickening and accentuation of skin markings produced by persistent inflammation and rubbing. Hand dermatitis can be particularly disabling because fissures and inflammation interfere with gripping, washing, and fine manual tasks. The morphology alone rarely identifies whether the cause is allergic, irritant, or atopic. A chronic eruption may have few obvious blisters despite being driven by allergy.\n\nDistribution provides important clues. Nickel may produce dermatitis beneath an earring, watch component, or trouser fastener. Footwear allergy can affect the dorsal feet in a pattern related to leather, rubber, adhesives, or shoe construction. Hair-dye allergy may prominently involve the hairline, ears, eyelids, and neck, sometimes with substantial facial swelling. Adhesive allergy can reproduce the outline of a dressing or wearable device. Plant exposure may leave linear streaks where allergenic sap contacted the skin; the fluid inside the resulting blisters does not spread the allergy.\n\nThe affected site does not always identify the original contact. Allergens can be transferred from hands to eyelids, face, or genital skin. Airborne particles or droplets can produce dermatitis of exposed facial and neck areas, with involvement of eyelids and skin folds helping distinguish some airborne patterns from purely light-induced eruptions. Clothing can trap allergens against the body, while contaminated tools, gloves, or surfaces can sustain exposure after the original task has ended.\n\nDisease can extend beyond the exact contact area, and intense localized dermatitis can be accompanied by a more widespread eczematous eruption. Systemic contact dermatitis is a distinct phenomenon in which systemic exposure to an allergen triggers dermatitis in a previously sensitized person. It is described with certain metals and medicines, but it should not be assumed from every widespread eruption or positive patch test. Similarly, systemic contact dermatitis is not synonymous with anaphylaxis: the former is a delayed dermatitis mechanism, whereas the latter is an acute systemic hypersensitivity reaction with different clinical features and risks."
    },
    {
      "heading": "Clinical investigation and patch testing",
      "text": "Investigation begins with the medical history and examination of the eruption. Relevant details include initial site, timing, recurrences, work tasks, hobbies, household products, topical treatments, and changes during weekends or holidays. Product names alone may be insufficient because formulations change, similarly named products differ between markets, and the allergen may be an impurity or minor ingredient. For occupational materials, ingredient documentation and safety data sheets can help reconstruct exposure, although they may not disclose every potentially sensitizing component.\n\nThe principal diagnostic procedure is the patch test. Standardized allergens, in specified concentrations and vehicles, are applied to the skin in small chambers, usually on the upper back. They are commonly left under occlusion for about 48 hours. The sites are then assessed at scheduled intervals, often including a reading around day 3 or 4 and, for selected allergens or protocols, another around day 7. Delayed readings matter because some allergic reactions appear late, while some irritant responses diminish rapidly.\n\nA baseline series tests allergens commonly relevant in a particular region. Additional series are selected according to the suspected exposures, such as hairdressing chemicals, rubber additives, acrylates, corticosteroids, or footwear materials. A small screening panel cannot detect every possible contact allergy. Testing a patient’s own products can add useful information, but concentration and preparation are crucial: a finished product may be irritating under occlusion, while dilution may reduce an allergen below the threshold needed to produce a reaction.\n\nReactions are graded according to features such as erythema, infiltration, papules, and vesicles. Interpretation is not simply a positive-or-negative laboratory exercise. A positive response establishes contact allergy to the tested material under the test conditions; its relevance to the presenting dermatitis must then be assessed. Relevance may be current, historical, or uncertain. Demonstrating that the allergen is actually present in a product, and that exposure fits the anatomical and temporal pattern, strengthens causal interpretation.\n\nFalse-negative results can occur when the responsible allergen was not tested, the concentration was inadequate, the material degraded, or the immune response was suppressed. Active extensive dermatitis can also complicate interpretation by producing nonspecific hyperreactivity. False-positive or misleading responses may result from irritation. A repeated open application test, performed under a controlled clinical protocol with a suitable product, can sometimes clarify the relevance of a leave-on preparation. Patch testing differs fundamentally from the skin-prick test, which primarily investigates immediate hypersensitivity rather than delayed contact allergy."
    },
    {
      "heading": "Differential diagnosis and special diagnostic problems",
      "text": "The most frequent diagnostic overlap is with irritant contact dermatitis. Irritant disease can follow a strong chemical injury or cumulative exposure to water, detergents, solvents, friction, and occlusion. Burning or stinging may be prominent, but symptoms are not sufficiently reliable to separate it from allergic disease. Allergy may begin after apparently uneventful use of a product, while cumulative irritation may also appear only after a long period. Patch testing identifies sensitization; it does not provide a direct positive test for every form of irritation.\n\nAtopic dermatitis and allergic contact dermatitis can coexist, and their distributions can overlap. Persistent facial, eyelid, hand, or treatment-site eczema may raise the possibility of a superimposed contact allergy, but none of these patterns is diagnostic by itself. Psoriasis, seborrheic dermatitis, fungal infection, and other inflammatory disorders may also resemble contact dermatitis. Vesicular hand eczema is a morphological pattern rather than proof of a specific allergen. Clinical context and targeted investigations determine whether these alternatives explain the eruption.\n\nImmediate contact reactions are distinguished principally by timing and morphology. Contact urticaria usually produces transient wheals within minutes of exposure rather than an eczematous eruption that develops over days. Protein contact dermatitis, often associated with handling foods or other biological materials, can combine chronic hand eczema with immediate symptoms after contact. In such cases, testing for immediate allergy can contribute information that conventional patch testing does not capture. Immediate latex allergy and delayed allergy to glove-manufacturing chemicals can also coexist.\n\nLight-related disease introduces another distinction. In photoallergic contact dermatitis, a substance becomes capable of provoking a delayed immune response after interaction with light, usually ultraviolet A. Some sunscreen ingredients and topical medicines have been implicated. Photopatch testing compares duplicate allergen applications, one of which receives a controlled ultraviolet exposure. Phototoxic reactions, by contrast, reflect light-dependent tissue injury without the same requirement for prior immune sensitization and often resemble an exaggerated sunburn.\n\nA skin biopsy can help exclude alternative diseases but usually cannot identify the responsible allergen or reliably separate allergic from irritant eczema. Typical histopathology includes spongiosis, or fluid accumulation between epidermal cells, with variable vesicle formation and inflammatory cell infiltration. Routine blood counts, total IgE measurements, and standard allergy blood tests do not establish ordinary allergic contact dermatitis. Likewise, a positive metal patch test alone does not demonstrate that an implanted device is causing local pain, loosening, or systemic symptoms; such problems require assessment of multiple competing explanations."
    },
    {
      "heading": "Treatment, exposure control, and disease course",
      "text": "Clinical management has two complementary aims: reducing active inflammation and interrupting exposure to the clinically relevant allergen. Anti-inflammatory treatment can improve the eruption without eliminating the underlying immune memory. Conversely, exposure removal may not produce immediate clearance because established inflammation and barrier damage take time to resolve. Continued low-level contact, an unidentified second allergen, or concurrent irritation can account for persistent disease despite an apparently appropriate change in products.\n\nTopical corticosteroids are widely used to suppress localized eczematous inflammation. Their effects include altered inflammatory gene expression and reduced immune-cell activity. Choice of preparation in clinical practice depends on anatomical site, severity, duration, and formulation. Thin skin and occluded areas absorb medicines differently from thick palmar or plantar skin. Adverse effects of prolonged or inappropriate exposure include skin atrophy and other local changes. Allergy to the corticosteroid molecule or an ingredient in its vehicle is an uncommon but important explanation for apparent treatment failure.\n\nNonsteroidal topical anti-inflammatory agents, including calcineurin inhibitors, are used in selected settings, particularly where repeated corticosteroid exposure is problematic. Emollients and barrier-supporting skin care address dryness and fissuring but can themselves contain relevant allergens. Wet dressings or compresses may be used in clinical care for acutely weeping lesions. Severe or extensive episodes are sometimes treated with systemic corticosteroids; the duration of treatment is clinically important because abrupt suppression followed by renewed inflammation can produce rebound disease.\n\nOther systemic anti-inflammatory treatments or phototherapy may be used for selected chronic, difficult cases, often when allergic contact dermatitis overlaps with another form of eczema. Evidence and regulatory approval vary by treatment and indication. Antihistamines do not directly block the principal T-cell mechanism of allergic contact dermatitis, although some agents may affect associated itching or sleep. Antibiotics address documented secondary bacterial infection rather than the allergic process itself. Crusting or weeping alone does not establish that infection is the main cause of deterioration.\n\nThe long-term course depends strongly on whether exposure can be identified and controlled. A person may remain sensitized after the visible dermatitis has resolved, and renewed exposure can provoke recurrence years later. Some allergens occur in many unrelated products, making complete avoidance difficult. Others are confined to a replaceable item, allowing substantial improvement when that source is removed. Persistent hand disease can also reflect ongoing wet work, friction, or atopic inflammation after the allergic component has diminished. Outcomes therefore depend on both allergen-specific control and the broader condition of the skin barrier."
    },
    {
      "heading": "Occupational disease and population-level prevention",
      "text": "Occupational allergic contact dermatitis occurs when work provides the sensitizing exposure, triggers disease in an already sensitized person, or materially aggravates an existing condition. High-exposure settings include hairdressing, health care, construction, cleaning, food handling, metalworking, dentistry, and manufacturing. The relevant allergen differs by task: hairdressers encounter dyes and persulfates; construction workers may encounter chromates and epoxy resins; dental personnel encounter acrylates; and health-care workers encounter glove chemicals, disinfectant ingredients, adhesives, and topical products.\n\nAttribution requires more than noting that dermatitis occurs in someone who works with chemicals. The chronology, anatomical pattern, specific materials, patch-test findings, and changes with exposure all contribute. Improvement away from work supports an occupational contribution but is not decisive, because treatment and domestic exposures may change simultaneously. Conversely, persistent disease during leave does not exclude an occupational origin: inflammation can take time to settle, and the same allergens may also occur at home.\n\nWorkplace prevention follows the logic of exposure control. Substitution of a sensitizing material, enclosed processes, reduced handling, and changes in work organization can decrease contact before reliance on personal protective equipment. Glove performance depends on chemical permeation, thickness, duration of use, and the particular task; “waterproof” does not mean impermeable to all chemicals. Gloves can also trap sweat, worsen irritation, or introduce allergens of their own. Occupational skin disease therefore sits at the intersection of individual diagnosis, industrial hygiene, and public health.\n\nPopulation-level interventions provide clear examples of exposure shaping disease. European restrictions on nickel release from items in prolonged contact with skin have been associated with reduced nickel sensitization in younger groups in several studied populations. European measures limiting soluble hexavalent chromium in cement addressed an important source of construction-related chromate allergy. Restrictions on methylisothiazolinone in cosmetics followed marked increases in contact allergy associated with its expanded use. The effects of such measures depend on product coverage, compliance, replacement chemicals, and remaining occupational or imported exposures.\n\nThe burden extends beyond the visible eruption. Chronic hand dermatitis can lead to work absence, task modification, retraining, or loss of employment. Itching, sleep disruption, appearance-related distress, and restrictions on routine activities reduce quality of life. Specialist surveillance networks track positive patch tests and exposure patterns, helping identify newly important allergens. These networks are valuable early-warning systems, but their results require interpretation alongside changes in referral practices, testing methods, and the composition of the tested population."
    },
    {
      "heading": "Historical development and research directions",
      "text": "Modern understanding developed from the recognition that certain eruptions represented a reproducible, acquired response to a specific contact substance. Josef Jadassohn’s work in 1895 is widely associated with the beginnings of diagnostic patch testing. Early investigators subsequently refined the controlled application of suspected allergens to intact skin. Bruno Bloch contributed to the study of experimental contact sensitization in the early twentieth century. These approaches helped distinguish contact allergy from nonspecific chemical injury before the cellular mechanisms were understood.\n\nThe twentieth-century development of cellular immunology explained why contact dermatitis differed from immediate antibody-mediated allergy. In the Gell and Coombs classification introduced in the 1960s, allergic contact reactions became a major example of delayed, type IV hypersensitivity. Later work established that antigen-presenting cells, multiple T-cell subsets, keratinocytes, and innate immune signals all contribute. The current model is therefore broader than the older shorthand of a single delayed hypersensitivity pathway.\n\nStandardization transformed patch testing from an individualized experiment into a comparative clinical method. Defined allergen concentrations, standardized chambers, agreed reading terminology, and baseline series made results more interpretable across centers. Regional series nevertheless remain necessary because exposure patterns differ. Multicenter surveillance has repeatedly identified changes in the importance of preservatives, fragrances, metals, rubber chemicals, and acrylates. In this field, clinical testing is both a diagnostic tool and a means of detecting consequences of changes in manufacturing and consumer behavior.\n\nResearch on skin sensitization also informs chemical safety assessment. The adverse outcome pathway for sensitization links chemical interaction with proteins, keratinocyte activation, dendritic-cell activation, and T-cell responses. Non-animal test methods examine different steps in this pathway, including peptide reactivity and cell-based activation responses. Combinations of such methods, computational models, and existing exposure information are used in defined approaches to hazard assessment. Predicting real-world disease remains more demanding than identifying sensitizing potential because dose, formulation, skin condition, and repeated exposure alter risk.\n\nCurrent mechanistic research uses single-cell analysis, spatial methods, and studies of tissue-resident memory to examine why responses differ between allergens and anatomical sites. Investigators are also studying why some patients remain symptomatic after recognized exposures are removed and whether molecular patterns can distinguish overlapping forms of eczema. New exposure problems continue to emerge from wearable medical devices, advanced adhesives, nail technologies, and replacement preservatives. For these products, identifying the precise allergen can be complicated by proprietary formulations, incomplete ingredient disclosure, chemical degradation, and changes between production batches."
    }
  ],
  "links": [
    "eczema",
    "allergy",
    "immune-system",
    "epidemiology",
    "type-four-hypersensitivity",
    "t-cell",
    "hapten",
    "lymph-node",
    "cytokine",
    "antibody",
    "urticaria",
    "inflammation",
    "anaphylaxis",
    "medical-history",
    "patch-test",
    "skin-prick-test",
    "irritant-contact-dermatitis",
    "psoriasis",
    "biopsy",
    "histopathology",
    "corticosteroid",
    "antihistamine",
    "public-health",
    "quality-of-life"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}